The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiling of advanced pancreatic ductal adenocarcinoma (PDAC): Role of ctDNA.
 
Angela Lamarca
Consulting or Advisory Role - Eisai; Ipsen; Nutricia; Nutricia (I); QED Therapeutics; Roche
Speakers' Bureau - Advanced Accelerator Applications; Incyte; Ipsen; Ipsen (I); Merck; Novartis (I); Pfizer; Pfizer (I)
Research Funding - Ipsen; Ipsen (I)
Travel, Accommodations, Expenses - Abbott Nutrition; Advanced Accelerator Applications; Bayer; Celgene; Delcath Systems; Ipsen; Ipsen (I); Mylan; NanoString Technologies (I); Novartis; Pfizer; Sirtex Medical
 
Mairead Geraldine McNamara
Honoraria - Novartis
Consulting or Advisory Role - Ipsen; Shire; Sirtex Medical
Speakers' Bureau - Nucana
Research Funding - Ipsen; Nucana; SERVIER
Travel, Accommodations, Expenses - Bayer; Novartis
 
Richard Hubner
Honoraria - Abbott Nutrition; Ipsen
Consulting or Advisory Role - BTG; Eisai; Shire
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Roche
 
Juan W. Valle
Honoraria - Ipsen
Consulting or Advisory Role - Agios; AstraZeneca; Debiopharm Group; Genoscience Pharma; Hutchison MediPharma; Imaging Equipment Limited; Incyte; Ipsen; Keocyt; Merck; Mundipharma; Novartis; Nucana; PCI Biotech; Pfizer; Pieris Pharmaceuticals; QED Therapeutics; SERVIER; Wren Laboratories
Speakers' Bureau - Imaging Equipment Limited; Ipsen; Novartis; Nucana
Travel, Accommodations, Expenses - Lilly; Nucana; Pfizer